Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma.
about
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinomaMulti-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma.Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy.Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions.Nasopharyngeal carcinoma: alternative treatment options after disease progression.Tetrandrine Induces Apoptosis of Human Nasopharyngeal Carcinoma NPC-TW 076 Cells through Reactive Oxygen Species Accompanied by an Endoplasmic Reticulum Stress Signaling Pathway.Capecitabine for treating head and neck cancer.Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: a multicenter prospective Phase II trial.Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.
P2860
Q30846827-A322DDCD-69A6-4ECF-AA54-022DC83E5176Q33411816-24319483-4F26-40EB-BD79-69E3FB7FFE71Q33428012-A0F86A8A-7174-4BE7-B2AB-80DB47A2741DQ33428455-94478FA5-E58A-408D-B596-BBD6520BDA5BQ33439361-1F276BBC-6FA8-451F-9744-BFC3E5F0DD96Q34074410-4414FAF9-7158-449F-950A-DD5812677F35Q36407458-FDDE28DE-CCF8-42A7-ADF2-8C040BC76470Q36766842-708CA0BE-6812-4AAF-92B3-6E7F7596C638Q36915011-44DCB37B-032C-4A81-9934-435BC52F248BQ37171008-DCFD5222-97F7-424E-A063-A09AE8949A52Q37705415-432A8E95-58ED-4B6D-9ABC-711A4D423703Q38740290-1F63247A-1E50-4CE1-A941-7117DE5640E7Q38825147-6E6FA310-AB0C-43F4-8C88-6EABBBCB5174Q41684880-4CF44AA9-7E94-4A1B-8AE1-0F8C6759ED80Q47729318-35F55F29-5860-45FB-B4F1-27AE39F5D98F
P2860
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Phase II study of gemcitabine ...... tant nasopharyngeal carcinoma.
@ast
Phase II study of gemcitabine ...... tant nasopharyngeal carcinoma.
@en
type
label
Phase II study of gemcitabine ...... tant nasopharyngeal carcinoma.
@ast
Phase II study of gemcitabine ...... tant nasopharyngeal carcinoma.
@en
prefLabel
Phase II study of gemcitabine ...... tant nasopharyngeal carcinoma.
@ast
Phase II study of gemcitabine ...... tant nasopharyngeal carcinoma.
@en
P2093
P356
P1433
P1476
Phase II study of gemcitabine ...... tant nasopharyngeal carcinoma.
@en
P2093
Chin-Yu Lin
Chuan-Cheng Wang
Jang-Yang Chang
Tsang-Wu Liu
Yu-Chieh Yu
P356
10.1002/HED.20310
P577
2006-01-01T00:00:00Z